Cosmo Pharmaceuticals NV
F:C43
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Cosmo Pharmaceuticals NV (C43) under the Base Case is 60.66 EUR per share.
Compared with the current market price of 58.4 EUR, the stock appears
Undervalued by 4% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cosmo Pharmaceuticals Does
Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market.
- Headquarters
- Ireland IE
- Employees
- 325
- IPO date
- May 18, 2016
Balance Sheet
Continue C43 Research
Decided on Cosmo Pharmaceuticals? Get an email when C43 reaches the price you’d buy at. Free with an account.
Other Cosmo Pharmaceuticals listings
What is the Intrinsic Value of one C43 stock?
The intrinsic value for
Cosmo Pharmaceuticals NV (C43) under the Base Case is 60.66 EUR.
Is C43 stock undervalued or overvalued?
Compared with the current market price of 58.4 EUR, the stock appears Undervalued by 4% .